Sung Ji Nam

Stock Analyst at Scotiabank

(0)
# 3272
Out of 5,218 analysts
69
Total ratings
54.17%
Success rate
4.40%
Average return
22 Stocks
Name Action Price Target Current % Upside Ratings Updated
Twist Bioscience
Maintains: Sector Outperform
50 54
47.54 13.59% 4 Nov 19, 2024
Pacific Biosciences
Maintains: Sector Outperform
7 6
1.96 206.12% 4 Nov 11, 2024
Veracyte
Maintains: Sector Outperform
40 44
43.21 1.83% 4 Nov 8, 2024
Castle Biosciences
Maintains: Sector Outperform
37 44
28.83 52.62% 5 Nov 6, 2024
CareDx
Maintains: Buy
40 35
22.94 52.57% 4 Nov 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sector Outperform
83 88
75.59 16.42% 1 Oct 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Sector Outperform
3
1.35 122.22% 1 Sep 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sector Perform
6 1
0.24 316.67% 5 Aug 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sector Outperform
176 164
143.9 13.97% 8 Aug 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sector Outperform
29 34
14.4 136.11% 2 Aug 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Sector Outperform
70
61.38 14.04% 1 Jun 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Apr 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sector Perform
n/a
n/a n/a 3 Oct 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
6
8.02 -25.19% 2 Jun 29, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Sector Outperform
36
34.67 3.84% 3 Jan 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Sector Outperform
15
6.29 138.47% 1 Jan 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
51 30
n/a n/a 2 Apr 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
718
527.13 36.21% 10 Feb 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Mar 17, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Nov 24, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
12
n/a n/a 1 Oct 23, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
21
n/a n/a 1 Sep 28, 2017